Higher persistence with valsartan compared with enalapril in daily practice
Satu J Siiskonen1, Nancy S Breekveldt-Postma1, Gábor Vincze2, Zeba M Khan3, Joëlle A Erkens1, Ron MC Herings11PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands; 2Novartis Pharma AG, Basel, Switzerland; 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, U...
Main Authors: | Satu J Siiskonen, Nancy S Breekveldt-Postma, Gábor Vincze, Zeba M Khan, Joëlle A Erkens, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-01-01
|
Series: | Vascular Health and Risk Management |
Online Access: | https://www.dovepress.com/higher-persistence-with-valsartan-compared-with-enalapril-in-daily-pra-peer-reviewed-article-VHRM |
Similar Items
-
Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared to Enalapril for Heart Failure Patients in Indonesia
by: Zakiyah N, et al.
Published: (2021-10-01) -
Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction
by: Marc de Gasparo, et al.
Published: (2000-06-01) -
Sacubitril-Valsartan Compared With Enalapril for the Treatment of Heart Failure: A Decision-Analytic Markov Model Simulation in China
by: Yue Wu, et al.
Published: (2020-07-01) -
Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure
by: Inder S Anand, et al.
Published: (2010-06-01) -
Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study
by: Swathi Pathadka, et al.
Published: (2021-01-01)